On Wednesday, Citi maintained a Buy rating on Assicurazioni Generali (BIT:GASI) SpA (G:IM) (OTC: ARZGY) and increased its price target to €32.67 from the previous €31.10. The adjustment reflects the firm's confidence in the insurer's growth prospects, citing several factors that could contribute to a stronger financial performance. InvestingPro data reveals the company's impressive 46% return over the past year, with shares currently trading near their 52-week high of $14.88.
Citi's analysis pointed to Generali's robust performance throughout 2024, with expectations of continued advancement driven by quicker than anticipated earnings per share (EPS) growth. The firm attributes this potential growth to a combination of efficiency improvements, solid solvency accumulation, available debt capacity, and increasing remittances. With a market capitalization of $44.39 billion and revenue growth of 8.36%, InvestingPro analysis shows the company maintains a GOOD overall Financial Health Score.
The upcoming Capital Markets Day (CMD) scheduled for January 30, is identified as a potential trigger for further positive revaluation of Generali's shares. Citi anticipates that the event might provide additional insight into the company's strategic direction and financial health, possibly influencing investor sentiment.
Citi's projections suggest that Generali's shares could deliver a 12% EPS growth, surpassing the consensus estimate of 8%. Additionally, the firm expects a 5% growing dividend yield for investors, coupled with the potential for upside from strategic cash and capital deployment.
The financial services company also highlighted Generali's valuation, noting that the projected price-to-earnings (P/E) ratio for 2025 stands at an adjusted 10.2 times EPS. Currently trading at 11.97x earnings with a 3.2% dividend yield, the company has maintained dividend payments for 33 consecutive years.
In light of these factors, Citi has raised its price target by 5% and anticipates a total expected return (ETR) of 23%. Furthermore, Generali has been included on the Citi European Focus List, indicating the firm's favorable outlook on the stock's prospects. According to InvestingPro, the stock is currently trading slightly above its calculated Fair Value, with additional insights available to subscribers.
In other recent news, Assicurazioni Generali SpA has been the focus of several significant developments. Morgan Stanley (NYSE:MS) upgraded Generali's stock from Equalweight to Overweight, citing parallels with AXA's past trajectory following its acquisition of XL, and increased the price target to €30.00. This suggests Morgan Stanley's confidence in Generali's potential for successful restructuring and growth.
Goldman Sachs initiated coverage on Generali shares with a Buy rating and set a price target of €31.50. The firm expressed a positive outlook for Generali's life insurance segment and projected new business growth to surpass estimates by approximately 10%.
Jefferies upgraded Generali's stock from Hold to Buy, setting a price target of €28.50. This upgrade reflects Jefferies' positive view of Generali's improved risk profile, growth prospects, and potential for higher capital returns.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.